{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:15:15Z","timestamp":1764688515916},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/ncponc0457","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T08:41:53Z","timestamp":1144226513000},"page":"184-185","source":"Crossref","is-referenced-by-count":3,"title":["Factors predictive for response of follicular and mantle-cell lymphoma to rituximab"],"prefix":"10.1038","volume":"3","author":[{"given":"Michael","family":"Pfreundschuh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncponc0457_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/JCO.2005.04.164","volume":"23","author":"M Ghielmini","year":"2005","unstructured":"Ghielmini M  et al. (2005) Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J Clin Oncol 23: 705\u2013711","journal-title":"J Clin Oncol"},{"key":"BFncponc0457_CR2","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","volume":"103","author":"M Ghielmini","year":"2004","unstructured":"Ghielmini M  et al. (2004) Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly \u00d7 4 schedule. Blood 103: 4416\u20134423","journal-title":"Blood"},{"key":"BFncponc0457_CR3","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1200\/JCO.2005.07.019","volume":"23","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W  et al. (2005) Treatment strategies in follicular lymphomas: current status and future perspectives. J Clin Oncol 23: 6394\u20136399","journal-title":"J Clin Oncol"},{"key":"BFncponc0457_CR4","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","volume":"23","author":"RI Fisher","year":"2005","unstructured":"Fisher RI  et al. (2005) New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 23: 8447\u20138452","journal-title":"J Clin Oncol"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc0457","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncponc0457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:41:51Z","timestamp":1684442511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BFncponc0457"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0457","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}